Susquehanna International Group’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $105K | Buy |
+154,243
| New | +$105K | ﹤0.01% | 5872 |
|
|
2025
Q1 | – | Sell |
-13,258
| Closed | -$14.5K | – | 6502 |
|
|
2024
Q4 | $14.5K | Buy |
+13,258
| New | +$14.5K | ﹤0.01% | 6022 |
|
|
2024
Q3 | – | Sell |
-119,722
| Closed | -$148K | – | 5793 |
|
|
2024
Q2 | $148K | Buy |
119,722
+86,067
| +256% | +$107K | ﹤0.01% | 4925 |
|
|
2024
Q1 | $63.6K | Buy |
33,655
+19,765
| +142% | +$37.4K | ﹤0.01% | 5129 |
|
|
2023
Q4 | $36.7K | Sell |
13,890
-58,852
| -81% | -$155K | ﹤0.01% | 5590 |
|
|
2023
Q3 | $167K | Buy |
72,742
+7,077
| +11% | +$16.3K | ﹤0.01% | 4656 |
|
|
2023
Q2 | $240K | Sell |
65,665
-66,870
| -50% | -$244K | ﹤0.01% | 4465 |
|
|
2023
Q1 | $473K | Buy |
+132,535
| New | +$473K | ﹤0.01% | 3891 |
|
|
2022
Q4 | – | Sell |
-28,573
| Closed | -$64K | – | 5984 |
|
|
2022
Q3 | $64K | Sell |
28,573
-136,438
| -83% | -$306K | ﹤0.01% | 5429 |
|
|
2022
Q2 | $411K | Buy |
165,011
+94,291
| +133% | +$235K | ﹤0.01% | 3591 |
|
|
2022
Q1 | $345K | Buy |
70,720
+23,216
| +49% | +$113K | ﹤0.01% | 4182 |
|
|
2021
Q4 | $537K | Buy |
47,504
+18,697
| +65% | +$211K | ﹤0.01% | 3689 |
|
|
2021
Q3 | $420K | Sell |
28,807
-16,307
| -36% | -$238K | ﹤0.01% | 3921 |
|
|
2021
Q2 | $526K | Sell |
45,114
-11,343
| -20% | -$132K | ﹤0.01% | 3827 |
|
|
2021
Q1 | $689K | Buy |
56,457
+33,219
| +143% | +$405K | ﹤0.01% | 3465 |
|
|
2020
Q4 | $291K | Sell |
23,238
-7,162
| -24% | -$89.7K | ﹤0.01% | 3924 |
|
|
2020
Q3 | $458K | Buy |
30,400
+7,854
| +35% | +$118K | ﹤0.01% | 3100 |
|
|
2020
Q2 | $553K | Buy |
+22,546
| New | +$553K | ﹤0.01% | 2820 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 4616 |
|